Superhouse Limited (SUPERHOUSE.NS)
INR 208.01
(-2.25%)
INR 208.01
(-2.25%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 262.88 Million | 292.79 Million | -14.18 Million | 840.99 Million | 556.43 Million | 415.29 Million |
| Net Income | 79.25 Million | 371.28 Million | 424.6 Million | 301.34 Million | 267.76 Million | 317 Million |
| Depreciation & Amortization | 153.83 Million | 160.06 Million | 144.98 Million | 153.28 Million | 147.75 Million | 153.8 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 20.05 Million | -250.51 Million | -595.62 Million | 299.64 Million | 53.84 Million | -116.41 Million |
| Other non-cash items | 121.53 Million | 11.94 Million | 11.85 Million | 86.71 Million | 87.06 Million | 60.9 Million |
| Investing Cash Flow | -273.45 Million | -474.95 Million | -111.76 Million | -136.3 Million | -97.63 Million | -90.13 Million |
| Investments in PPE | -263.03 Million | -434.56 Million | -306.99 Million | -114.5 Million | -119.96 Million | -125.07 Million |
| Acquisitions | 43.21 Million | -30.29 Million | 80.23 Million | -1.29 Million | -238 Thousand | 11.72 Million |
| Investment purchases | -61.27 Million | -52.85 Million | -6.43 Million | -100 Thousand | -500 Thousand | -8.36 Million |
| Sales/Maturities of investments | 340 Thousand | 40.22 Million | 397 Thousand | 54 Million | 46.37 Million | -11.72 Million |
| Other Investing Activities | 7.29 Million | 2.53 Million | 121.02 Million | -74.4 Million | -23.31 Million | 43.29 Million |
| Financing Cash Flow | -38.65 Million | 165.11 Million | 40.81 Million | -478.07 Million | -472.15 Million | -308.32 Million |
| Debt repayment | -27.63 Million | -318.11 Million | -205.19 Million | -127.31 Million | -137.21 Million | -84.88 Million |
| Dividends payments | -11.02 Million | -11.02 Million | -11.02 Million | -8.82 Million | -13.29 Million | -13.29 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -23.86 Million | 494.24 Million | 257.02 Million | -341.94 Million | -321.64 Million | -210.14 Million |
| Accounts receivables | 308.7 Million | -313.81 Million | -178.24 Million | -23.57 Million | 129.76 Million | 51.71 Million |
| Accounts payables | -487.05 Million | -59.52 Million | 442.8 Million | -3.79 Million | -274.57 Million | -89.53 Million |
| Inventory | 374.21 Million | -35.06 Million | -819.23 Million | 228.09 Million | 43.98 Million | 33.17 Million |
| Other working capital | -175.8 Million | 157.89 Million | -40.94 Million | 98.9 Million | 154.66 Million | -111.77 Million |
| Cash at beginning of period | 695.92 Million | 256.78 Million | 341.92 Million | 115.31 Million | 128.66 Million | 111.83 Million |
| Cash at end of period | 573.49 Million | 239.74 Million | 256.78 Million | 341.92 Million | 115.31 Million | 128.66 Million |
| Capital Expenditure | -263.03 Million | -434.56 Million | -306.99 Million | -114.5 Million | -119.96 Million | -125.07 Million |
| Effect of forex changes on cash | - | - | - | - | 1.00 | -1.00 |
| Net cash flow / Change in cash | -122.43 Million | -17.04 Million | -85.14 Million | 226.61 Million | -13.35 Million | 16.83 Million |
| Free Cash Flow | -151.99 Thousand | -141.77 Million | -321.18 Million | 726.48 Million | 436.47 Million | 290.22 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 22.84 Million | 79.25 Million | 21.5 Million | 59.55 Million | 15.06 Million | 371.28 Million |
| Depreciation & Amortization | - | 153.83 Million | 44.18 Million | 44.18 Million | 42.77 Million | 160.06 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 20.05 Million | - | - | - | -250.51 Million |
| Other non-cash items | -22.84 Million | 121.53 Million | -21.5 Million | -59.55 Million | -15.06 Million | 11.94 Million |
| Investing Cash Flow | - | -273.45 Million | - | - | - | -474.95 Million |
| Investments in PPE | - | -263.03 Million | - | - | - | -434.56 Million |
| Acquisitions | - | 43.21 Million | - | - | - | -30.29 Million |
| Investment purchases | - | -61.27 Million | - | - | - | -52.85 Million |
| Sales/Maturities of investments | - | 340 Thousand | - | - | - | 40.22 Million |
| Other Investing Activities | - | 7.29 Million | - | - | - | 2.53 Million |
| Financing Cash Flow | - | -38.65 Million | - | - | - | 165.11 Million |
| Debt repayment | - | -27.63 Million | - | - | - | -318.11 Million |
| Dividends payments | - | -11.02 Million | - | - | - | -11.02 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -23.86 Million | - | - | - | 494.24 Million |
| Accounts receivables | - | 308.7 Million | - | - | - | -313.81 Million |
| Accounts payables | - | -487.05 Million | - | - | - | -59.52 Million |
| Inventory | - | 374.21 Million | - | - | - | -35.06 Million |
| Other working capital | - | -175.8 Million | - | - | - | 157.89 Million |
| Cash at beginning of period | - | 695.92 Million | 768.41 Million | 680.04 Million | 695.92 Million | 256.78 Million |
| Cash at end of period | - | 573.49 Million | 856.79 Million | 768.41 Million | 781.47 Million | 239.74 Million |
| Capital Expenditure | - | -263.03 Million | - | - | - | -434.56 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | -122.43 Million | 88.37 Million | 88.37 Million | 85.54 Million | -17.04 Million |
| Free Cash Flow | - | -151.99 Thousand | 88.37 Million | 88.37 Million | 85.54 Million | -141.77 Million |
MPFRY
300253
3MINDIA
CONCORDBIO
RAMCOSYS
CRISIL